Vaccines

06 Jan 2021 Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections
06 Jan 2021 INOVIO’s VGX-3100 demonstrates positive Phase 2 efficacy in treatment of precancerous vulvar dysplasia caused by HPV-16/18
06 Jan 2021 European Commission Authorizes COVID-19 Vaccine Moderna in Europe
06 Jan 2021 Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms
06 Jan 2021 Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine
06 Jan 2021 Precigen Announces Clearance of IND to Initiate Phase I Study of PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP)
05 Jan 2021 Emergex Vaccines signs Collaboration Agreement with Brazil’s Bio-Manguinhos/Fiocruz for the Development of a COVID-19 Vaccine
02 Jan 2021 EpiVax and EpiVax Therapeutics Advance COVID-19 Vaccine Program, EPV-CoV-19
02 Jan 2021 Moderna Announces Publication of Results from the Pivotal Phase 3 Trial of the Moderna COVID-19 Vaccine in The New England Journal of Medicine
30 Dec 2020 AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK
29 Dec 2020 Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico
29 Dec 2020 IMV Reports Update on COVID-19 Vaccine Program
29 Dec 2020 Arcturus Therapeutics Received Approval from Singapore Health Sciences Authority to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate and Provides New and Updated Clinical and Preclinical Data
24 Dec 2020 Altimmune Provides an Update on its Investigational New Drug Application for a Phase 1 AdCOVID™ Clinical Trial
24 Dec 2020 Aurobindo Pharma and COVAXX Sign an Exclusive Agreement to Develop and Commercialize COVID-19 Vaccine UB-612 for India and UNICEF
23 Dec 2020 Serum Institute Of India And Dynavax Announce First Participants Dosed In The Phase 1/2 Clinical Trial For A COVID-19 Vaccine
23 Dec 2020 Ocugen and Bharat Biotech to Co-Develop COVAXIN™, a Whole-Virion Inactivated COVID-19 Vaccine, for the US Market
23 Dec 2020 Evaxion Biotech Doses First Patient in Phase I/IIa Melanoma Trial of Cancer Vaccine EVX-02 in Combination With Checkpoint Inhibitors
23 Dec 2020 Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine
22 Dec 2020 Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine
22 Dec 2020 Ultimovacs ASA Initiates FOCUS Phase II Trial for Universal Cancer Vaccine, UV1, in Head and Neck Cancer Patients Receiving Pembrolizumab
21 Dec 2020 Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine
19 Dec 2020 Moderna Announces FDA Authorization of Moderna COVID-19 Vaccine in U.S.
18 Dec 2020 Enesi Pharma and Imperial College London Collaborate to Develop Thermostable RNA Vaccines with Potential to Eliminate Cold Chain and Transform Global Vaccination Logistics for COVID-19
18 Dec 2020 Moderna Receives FDA Advisory Committee Vote Supporting Emergency Use for Moderna’s Vaccine Against COVID-19 in the United States

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top